BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 92877)

  • 1. Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor.
    Auer LM; Marth E; Heppner F; Holasek A
    Acta Neurochir (Wien); 1979; 49(3-4):207-17. PubMed ID: 92877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase inhibitors in cerebrospinal fluid in multiple sclerosis.
    Price P; Cuzner ML
    J Neurol Sci; 1979 Jul; 42(2):251-9. PubMed ID: 90128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
    Balldin G; Gustafsson EL; Ohlsson K
    Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A; Ohlsson K
    Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trasylol prevents trypsin-induced shock in dogs.
    Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
    Lasson A; Dittmann B; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The content of the protein markers of hemato-encephalic barrier permeability in the cerebrospinal fluid in severe craniocerebral trauma].
    Kuksinskiĭ VA; Lutsik AA; Churliaev IuA; Lykova OF; Nikiforova NV; Martynenkov VIa; Bykov KV
    Zh Vopr Neirokhir Im N N Burdenko; 1998; (2):26-7. PubMed ID: 9720164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of inflammatory proteinase, medullasin, by alpha 2-macroglobulin and ovomacroglobulin.
    Ikai A; Nakashima M; Aoki Y
    Biochem Biophys Res Commun; 1989 Feb; 158(3):831-6. PubMed ID: 2465765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
    Balldin G; Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
    Gosteva LA
    Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinolytic inhibitory proteins of the hemostaseologic system in normal, inflammatory and bloody cerebrospinal fluid].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1980 Jun; 32(6):328-37. PubMed ID: 6157172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental investigations on the proportional inhibitory capacity of different proteinase inhibitors in cases of chronic otitis media and cholesteatoma (author's transl)].
    Kastenbauer ER; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Oct; 57(10):869-71. PubMed ID: 82895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of myelin basic protein on the protease inhibitors alpha 1 antitrypsin and alpha 2 macroglobulin.
    van der Veen RC; Brinkman CJ; Hommes OR; Lamers KJ
    Acta Neurol Scand; 1985 Mar; 71(3):199-205. PubMed ID: 2581414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteinase inhibitor activity of blood plasma and cerebrospinal fluid in patients with pituitary adenomas before and after proton therapy].
    Zargarova OP; Konnova LA
    Vopr Med Khim; 1983; 29(6):96-8. PubMed ID: 6199897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Marker proteins in cerebrospinal fluid of patients with grave craniocerebral injury].
    Kuksinskiĭ VA; Churliaev IuA; Nikiforova NV; Lutsik AA; Lykova OF
    Klin Lab Diagn; 1997 Nov; (11):11-2. PubMed ID: 9471311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of serum protease inhibitors during fetal and postnatal development of the pig.
    Weström BR; Karlsson BW; Svendsen J
    Biol Neonate; 1982; 41(1-2):22-31. PubMed ID: 6175350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Main proteolytic inhibitors in ocular herpes].
    Chesnokova NB; Kasavina BS; Maĭchuk IuF; Kazachenko MA; Shchipanova AI
    Vopr Med Khim; 1981; 27(5):663-5. PubMed ID: 6171934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha-2 macroglobulin from cerebrospinal fluid in neurosurgical diseases].
    Vasil'eva TG; Dobrogorskaia LN; Kraeva LN; Goncharova VP
    Vopr Med Khim; 1989; 35(6):48-51. PubMed ID: 2483469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of malignant cell invasion in vitro by a proteinase inhibitor.
    Latner AL; Longstaff E; Pradhan K
    Br J Cancer; 1973 Jun; 27(6):460-4. PubMed ID: 4352791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.